Hahn: FDA won’t make regulatory decisions based on preprints or news releases

The COVID-19 pandemic has upended the long standing model for publishing clinical data as researchers and drugmakers race to share the latest findings about treatment and vaccine candidates at a time when case counts and deaths are still rising.